AsiaStrategy and Plume are exploring a joint venture to create and distribute tokenized real-world asset products in Asia and other markets outside the U.S. Plume will provide the technology and regulatory framework, while AsiaStrategy and Sora Ventures will focus on sourcing assets and developing distribution channels in Japan, South Korea, Hong Kong, Thailand, and the UAE. The products aim to combine traditional assets with compliant blockchain issuance, but details and rollout plans are still being finalized, with no products issued yet.
AsiaStrategy and Plume's tokenization venture outside the U.S. is the focus here, with Pluang market data providing context. As of Oct 07, 2026 01:12 WIB, among 50 major cryptocurrencies tradable on Pluang, 24 rose and 25 fell. Notable movers include UNI at Rp154.755 with a 1-day change of -3.26% and a typical hold time of 65 days, SAND at Rp1.170 down 3.16%, and ADA at Rp4.877 up 2.93%.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
